The bear case carries stronger evidentiary weight but not enough to justify a full exit. The bull's "earnings recovery" thesis is contaminated by a $303M one-time securities gain in Q2 2026; stripping that out, underlying quarterly EPS power is $1.30-1.40 — annualizing to ~$5.20-5.60, essentially in line with the $5.63 TTM figure. This collapses the "74% earnings recovery" narrative and transforms the 16.65x forward P/E into a 28-31x normalized multiple — actually more expensive than the headline 29x TTM. The technical picture shows the 200 SMA "holding" by 45 cents intraday is the opposite of conviction; with price below the 10 EMA, 50 SMA, 20 SMA, and VWMA simultaneously, this is a last-stand pattern, not a launchpad. The bear's balance sheet analysis reveals structural fragility: negative tangible book value, 437% D/E, a current ratio that has compressed from 1.72 to 1.24, and Q1 2025 FCF of -$1.16B. Aggressive buybacks ($4B annually against ~$3B of net income) are masking fragility. Litigation accruals are accelerating (+46% YoY in current liabilities), not de-risking. The bull wins on moat quality and dividend durability — 67+ years of increases and iconic brands like Post-it, Scotch, and Command justify some valuation premium. The expected-value math under bear probability weights (55-60% down/15-20% up) tilts modestly negative, supporting a cautious stance without a full Sell given the still-intact 200 SMA, real brand moat, and possibility of a macro pivot.

POSITION STRATEGY: Trim existing positions by 30-40% at current levels ($163-165), prioritizing any lots with the lowest cost basis. The setup does not warrant adding exposure here, and the asymmetric downside from a 200 SMA breakdown is meaningfully larger than the upside from a successful defense.

HARD STOP: Hold the remaining 60-70% of the position with a hard stop at a daily close below $158 (roughly 3% below current, just under the 200 SMA at $159.47). A confirmed break of the 200 SMA on a closing basis is the technical signal to exit the residual position; do not wait for a deeper drawdown, as the next support is materially lower at $152 (March-April consolidation) and $145 (50% retracement).

NEW POSITIONS: Do not initiate new long positions until two confirmations occur: (a) a successful defense of the 200 SMA with a reclaim of the 10 EMA at $165 and ideally the 20 SMA at $165.58, and (b) Q3 2026 earnings that demonstrate clean operating EPS in the $1.40-1.55 range without another one-time gain providing a tailwind.

RE-ENTRY TRIGGER: A daily close above the 50 SMA at $172.87 with above-average volume would re-establish the intermediate-term uptrend and would warrant adding back to a full-weight position. Until then, the bias is to stay light.

RISK MONITORING: Monitor two specific catalysts as risk events: (a) any new PFAS litigation developments, particularly state AG filings or class-action expansions, as the existing accruals are accelerating, not de-risking; (b) any dividend action at the next announcement — a freeze or cut would be a high-conviction sell signal and would likely trigger an 8-15% gap-down.

POSITION SIZING: If the technical setup confirms, size to a starter position of 0.5x standard weight, with adds on a successful retest of the 50 SMA. Do not go to full weight until the dividend payout ratio is shown to be sustainable on a normalized (not one-time-gain-boosted) earnings base.

HEDGING: Given the macro setup of high rates and weak cyclicals, consider hedging residual MMM exposure with a long position in a rate-sensitive industrial peer (e.g., HON or EMR) that has cleaner balance sheet metrics and less litigation overhang — this captures any cyclical re-rating while limiting idiosyncratic 3M risk.

The investment plan's "Underweight" recommendation is well-grounded in three key risks that outweigh the bull case: (1) The "cheap" 16.65x forward P/E is an optical illusion — stripping the $303M one-time securities gain from Q2 2026 reveals normalized EPS of ~$5.20-5.60, making the true multiple 28-31x, more expensive than the 29x TTM; (2) The technical setup is a "last-stand" pattern with price simultaneously below the 10 EMA, 20 SMA, 50 SMA, and VWMA, with the 200 SMA at $159.47 holding by mere cents; (4) Balance sheet fragility (negative tangible book value, 437% D/E, current ratio compressing from 1.72 to 1.24, Q1 2025 FCF of -$1.16B) combined with accelerating PFAS litigation accruals (+46% YoY) creates asymmetric downside. While the brand franchise (Scotch, Post-it, Command) and 67+ year dividend track record are legitimate, they don't compensate for the structural risks. The macro backdrop of a 10Y breakout from a 40-year downtrend further pressures cyclicals. The plan's trim recommendation at $163-165 with a $158 stop on the remainder is the optimal execution path.

Stop loss: $158.00

Sizing: Trim 30-40% of existing position at current levels ($163-165); hold remaining 60-70% with hard stop at $158 daily close